Rheumatology Therapeutics Market 2019 Size, Share, Key Players, Factor Analysis, Segments, Market Dynamics and Regional Forecast to 2026

Rheumatology diseases are a set of conditions caused due to inflammation of joints. The diseases adversely impact the supporting or connecting structures of the body such as joints, ligaments, muscles, spine, and tendons. The diseases also affect some organs of the body. There are over 100 types of rheumatic diseases. Genetic and environmental factors such as unhealthy diet and changing lifestyle may lead to rheumatology diseases. Some of the common types of rheumatology diseases include, osteoarthritis, ankylosing spondylitis, rheumatoid arthritis, gout, psoriatic arthritis, reactive arthritis, fibromyalgia, and scleroderma.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/796

Management and treatment of rheumatology diseases involves medications, proper nutrition, exercises, and physical therapies with surgical treatment to cure joint damage. Better outcomes can be achieved by early diagnosis of these diseases. Disease-modifying antirheumatic drugs (DMARDs) are also used for the treatment of rheumatologic diseases.

Rheumatology Therapeutics Market Drivers

Increasing prevalence of rheumatology arthritis is a major factor boosting growth of the global rheumatology therapeutics market. For instance, according to the Centers for Disease Control and Prevention (CDC) in 2013, around 52.5 million of adults in the U.S. suffered from rheumatology arthritis, which equals to 23% of the population with 1% being the prevalence rate of rheumatology diseases globally. According to the Global Burden of Disease 2010 study data, prevalence rate for knee arthritis globally was 3.8% and for hip osteoarthritis was 0.85% globally.

Moreover, increasing technological advancements in the medical field and increasing government expenditure on the healthcare sector also contribute to growth of the rheumatology therapeutics market. For instance, according to the World Health Organization (WHO) in 2014, government spent 15.5% on healthcare sector.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/796

Rheumatology Therapeutics Market Restraints

Some of the factors that hinder growth of the market include, launch and increasing demand for biosimilars and patent expiry of some drugs used in the treatment of rheumatology diseases. For instance, the patent for Enbrels drug expired in 2012.

The global rheumatology therapeutics market is segmented by disease type, by drug type, by end user, and by region. The rheumatoid arthritis segment is expected to hold dominant position due to high prevalence of rheumatoid arthritis.

On the basis of disease type, the rheumatology therapeutics market is segmented into:

• Osteoarthritis
• Ankylosing spondylitis
• Rheumatoid arthritis
• Gout
• Psoriatic arthritis
• Reactive arthritis
• Fibromyalgia
• Scleroderma
• Others

On the basis of drug type, the rheumatology therapeutics market is segmented into:

• Disease-Modifying Antirheumatic Drugs (DMAD’s)
• Humira
• Remicade
• Cyclosporine
• Methotrexate
• Biologics
• Tofacitinib
• Others

On the basis of end-user, the rheumatology therapeutics market is segmented into:

• Hospitals
• Medical clinics

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/rheumatology-therapeutics-market-796

Rheumatology Therapeutics Market Regional Analysis

North America is expected to hold dominant position in the market over the forecast period. This is attributed to factors such as high prevalence of rheumatology diseases, changing lifestyle, and developed medical and healthcare sector. For instance, according to the Centers for Disease Control and Prevention (CDC), around 27 million people are suffering with Clinical arthritis in the U.S, around 8 million people with Gout syndrome, and 78 million adults are at risk to suffer from clinical arthritis till 2040.

Increase prevalence of rheumatology diseases and developing healthcare sector is expected to boost growth of the market in Asia Pacific

Rheumatology Therapeutics Market Competitive Landscape

Major players in the market are focused on adopting partnership and collaboration strategies to enhance their market share. For instance, licensing agreement of Bri Stol-Myers Squibb with Alder Biopharmaceuticals Company and the major acquisition of Ardea Biosciences by AstraZeneca are one of the important agreements between 2007 and 2012.

Major players operating the global rheumatology therapeutics market include, Eli Lily, AstraZeneca, Alder Biopharmaceuticals, Rigel pharma, Abbott Laboratories, Pfizer, Amgen, Janssen Biotech, and Merck Co. Inc.

Table of Content

Global Rheumatology Therapeutics Market Research Report
Section 1: Global Rheumatology Therapeutics Industry Overview
Section 2: Global Economic Impact on Rheumatology Therapeutics Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Rheumatology Therapeutics Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Rheumatology Therapeutics Market Forecast

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837